by David Eyre | Mar 1, 2018 | Briefings, US & International
Extending the patent term for such high value patented products can be particularly significant for rights holders even when the additional term is mere days. A supplementary protection certificate is intended to partially compensate a patent holder for the patent...
by Sean Hughes | Mar 1, 2018 | Briefings, US & International
Europe The Enlarged Board of Appeal in G 02/08 clarified that second medical use claims to new and inventive dosage regimes are patentable, even where the substance or composition, and the disease to be treated, are the same as in the prior art. Nevertheless, the...
by Carolyn Haywood | Mar 1, 2018 | Briefings, Designs & Copyright, Trademarks
With respect to intellectual property, one of the important proposals in the draft Withdrawal Agreement was the creation of “parallel” UK rights, without the need for re-examination, for owners of EU trade marks or registered Community designs,...
by David Eyre | Feb 1, 2018 | UK, UPC
At the beginning of 2017 the Preparatory Committee of the Unified Patent Court thought that it would be likely that the systems of the UPC would begin provisional operation before summer 2017 in advance of the UPC agreement coming into force later that year. It...
by Carolyn Haywood | Feb 1, 2018 | Briefings, EPO
During first instance proceedings, Swarovski-Optik KG’s European patent, EP1746451, was upheld with limited claims. However, during second instance (appeal) proceedings, the patent was revoked. Swarovski-Optik KG filed a petition for review by the Enlarged Board...
Recent Comments